Javier Baena

1.0k total citations
18 papers, 168 citations indexed

About

Javier Baena is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Javier Baena has authored 18 papers receiving a total of 168 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 3 papers in Neurology. Recurrent topics in Javier Baena's work include Lung Cancer Research Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Javier Baena is often cited by papers focused on Lung Cancer Research Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Javier Baena collaborates with scholars based in Spain, Italy and United States. Javier Baena's co-authors include Luis Paz‐Ares, Flora López-López, Ramón Yarza, María Dolores Folgueira, Carmen Díaz‐Pedroche, Carlos Gómez-Martín, Carlos Lumbreras, D. Paredes, Jon Zugazagoitia and Carmen Kahatt and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Cell and Clinical Cancer Research.

In The Last Decade

Javier Baena

12 papers receiving 164 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier Baena Spain 6 118 49 34 28 23 18 168
Jianbang Chiang Singapore 10 121 1.0× 21 0.4× 31 0.9× 54 1.9× 16 0.7× 40 265
Kristen Labbe United States 6 146 1.2× 65 1.3× 51 1.5× 63 2.3× 10 0.4× 6 233
Zachary Dovey United States 8 94 0.8× 65 1.3× 94 2.8× 36 1.3× 45 2.0× 24 245
Rita Poon United States 6 53 0.4× 50 1.0× 16 0.5× 30 1.1× 19 0.8× 8 231
Sinem Namdaroğlu Türkiye 8 137 1.2× 131 2.7× 25 0.7× 16 0.6× 7 0.3× 30 252
Yoo‐Na Kim South Korea 10 84 0.7× 17 0.3× 35 1.0× 51 1.8× 23 1.0× 38 272
Olivia D. Lara United States 8 107 0.9× 34 0.7× 21 0.6× 47 1.7× 8 0.3× 28 190
Clémence Basse France 7 147 1.2× 39 0.8× 59 1.7× 61 2.2× 18 0.8× 27 252
Ryoichi Honda Japan 8 82 0.7× 29 0.6× 50 1.5× 38 1.4× 10 0.4× 26 183
Magdalena Corona Spain 6 101 0.9× 117 2.4× 9 0.3× 16 0.6× 17 0.7× 18 182

Countries citing papers authored by Javier Baena

Since Specialization
Citations

This map shows the geographic impact of Javier Baena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Baena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Baena more than expected).

Fields of papers citing papers by Javier Baena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Baena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Baena. The network helps show where Javier Baena may publish in the future.

Co-authorship network of co-authors of Javier Baena

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Baena. A scholar is included among the top collaborators of Javier Baena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Baena. Javier Baena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Paz‐Ares, Luis, et al.. (2025). Unmet Needs in Maintenance Therapy for Extensive Stage Small Cell Lung Cancer. Clinical Lung Cancer. 26(3). 168–178.
2.
Ponce-Aix, Santiago, Alejandro Navarro, Laura Mezquita, et al.. (2025). Safety and efficacy of lurbinectedin plus atezolizumab as second-line treatment for advanced small-cell lung cancer: Results of the 2SMALL phase 1/2 study (NCT04253145).. Journal of Clinical Oncology. 43(16_suppl). 8013–8013.
3.
Cabo, Horacio, Esther Conde, Susana Hernández, et al.. (2024). Clinical Utility of Combined Tissue and Plasma Next-Generation Sequencing in Patients With Advanced, Treatment-Naïve NSCLC. JTO Clinical and Research Reports. 6(3). 100778–100778.
4.
Fulgenzi, Claudia Angela Maria, Talal El Zarif, Elio Adib, et al.. (2024). Efficacy of immune checkpoint inhibitors in patients with HIV-associated unresectable HCC (uHCC): Propensity-score matched analyses from two international consortia.. Journal of Clinical Oncology. 42(3_suppl). 442–442. 1 indexed citations
5.
Zugazagoitia, Jon, et al.. (2024). Facts and Hopes on Cancer Immunotherapy for Small Cell Lung Cancer. Clinical Cancer Research. 30(14). 2872–2883. 7 indexed citations
6.
Baena, Javier, et al.. (2023). Future Perspectives in the Second Line Therapeutic Setting for Non-Oncogene Addicted Non-Small-Cell Lung Cancer. Cancers. 15(23). 5505–5505. 5 indexed citations
7.
Conde, Esther, Susana Hernández, Javier Baena, et al.. (2023). Comparison between liquid biopsy and tissue NGS in two cohorts of advanced NSCLC.. Journal of Clinical Oncology. 41(16_suppl). e21043–e21043.
8.
Alaiwi, Sarah Abou, Talal El Zarif, Ryan A. Denu, et al.. (2023). Safety and efficacy of immune checkpoint inhibitors (ICIs) in patients (pts) with cardiac metastases (mets) from solid tumors.. Journal of Clinical Oncology. 41(16_suppl). 2653–2653. 1 indexed citations
9.
Baena, Javier, et al.. (2023). EP14.02-07 Atypical Response to Metronomic Chemotherapy in a Patient with Advanced Thymoma. Journal of Thoracic Oncology. 18(11). S719–S720.
10.
Moutafi, Myrto, Javier Baena, Ioannis Vathiotis, et al.. (2022). Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer. Journal for ImmunoTherapy of Cancer. 10(8). e004757–e004757. 25 indexed citations
11.
Baena, Javier, et al.. (2022). Emerging immune checkpoint inhibitors for the treatment of non-small cell lung cancer. Expert Opinion on Emerging Drugs. 27(3). 289–300. 5 indexed citations
12.
13.
Baena, Javier, et al.. (2021). Lurbinectedin in the Treatment of Relapsed Small Cell Lung Cancer. Future Oncology. 17(18). 2279–2289. 19 indexed citations
14.
Yarza, Ramón, D. Paredes, Flora López-López, et al.. (2020). SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death. European Journal of Cancer. 135. 242–250. 69 indexed citations
15.
Trama, Annalisa, Claudia Proto, Jennifer G. Whisenant, et al.. (2020). Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience. Cancer Cell. 38(5). 602–604. 4 indexed citations
16.
Baena, Javier, et al.. (2020). Subclinical Arteriosclerosis is Associated with Common Vascular Risk Factors in Long-Term Survivors of Testicular Cancer. Journal of Clinical Medicine. 9(4). 971–971.
17.
Sánchez‐Muñoz, Alfonso, et al.. (2019). Targeted treatment approaches in refractory germ cell tumors. Critical Reviews in Oncology/Hematology. 143. 130–138. 19 indexed citations
18.
Giner, Rosa M., et al.. (1990). [Delayed gastric emptying following subtotal gastrectomy].. PubMed. 78(1). 31–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianbang Chiang Breakdown of academic impact, for papers by Kristen Labbe Breakdown of academic impact, for papers by Zachary Dovey Breakdown of academic impact, for papers by Rita Poon Breakdown of academic impact, for papers by Sinem Namdaroğlu Breakdown of academic impact, for papers by Yoo‐Na Kim Breakdown of academic impact, for papers by Olivia D. Lara Breakdown of academic impact, for papers by Clémence Basse Breakdown of academic impact, for papers by Ryoichi Honda Breakdown of academic impact, for papers by Magdalena Corona
Rankless by CCL
2026